Published in Am J Kidney Dis on November 01, 2004
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet (2008) 9.00
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med (2011) 3.19
MYO1E mutations and childhood familial focal segmental glomerulosclerosis. N Engl J Med (2011) 2.65
Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome. J Am Soc Nephrol (2009) 1.89
MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br J Haematol (2011) 1.67
Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis. Clin J Am Soc Nephrol (2010) 1.60
In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress. PLoS Genet (2015) 1.52
Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation. Transplantation (2015) 1.47
APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease. J Am Soc Nephrol (2011) 1.43
NPHS2 variation in sporadic focal segmental glomerulosclerosis. J Am Soc Nephrol (2007) 1.36
Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations. Am J Hum Genet (2013) 1.35
Pathogenesis and therapy of focal segmental glomerulosclerosis: an update. Pediatr Nephrol (2010) 1.24
Recent progress in the pathophysiology and treatment of FSGS recurrence. Am J Transplant (2013) 1.13
Genetics of focal segmental glomerulosclerosis and human immunodeficiency virus-associated collapsing glomerulopathy: the role of MYH9 genetic variation. Semin Nephrol (2010) 1.13
Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis. Kidney Int (2012) 1.10
Minimal change nephropathy and focal segmental glomerulosclerosis. Semin Immunopathol (2007) 1.05
Essential hypertension and risk of nephropathy: a reappraisal. Curr Opin Nephrol Hypertens (2010) 1.04
NPHS2 variation in focal and segmental glomerulosclerosis. BMC Nephrol (2008) 1.04
Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease. Nat Med (2016) 1.02
The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review. J Transplant (2011) 0.97
Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy. Transplantation (2013) 0.92
Changing histologic spectrum of adult nephrotic syndrome over five decades in north India: A single center experience. Indian J Nephrol (2014) 0.92
Up-regulation of the homophilic adhesion molecule sidekick-1 in podocytes contributes to glomerulosclerosis. J Biol Chem (2010) 0.91
The role of alpha-actinin-4 in human kidney disease. Cell Biosci (2015) 0.89
CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo. Am J Physiol Renal Physiol (2010) 0.88
Polymorphisms in the non-muscle myosin heavy chain gene (MYH9) are associated with lower glomerular filtration rate in mixed ancestry diabetic subjects from South Africa. PLoS One (2012) 0.88
Podocyte pathology and nephropathy - sphingolipids in glomerular diseases. Front Endocrinol (Lausanne) (2014) 0.87
A new locus for familial FSGS on chromosome 2p. J Am Soc Nephrol (2010) 0.87
Exclusion of homozygous PLCE1 (NPHS3) mutations in 69 families with idiopathic and hereditary FSGS. Pediatr Nephrol (2008) 0.86
Glomerular diseases: FSGS. Clin J Am Soc Nephrol (2013) 0.86
Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS. Clin J Am Soc Nephrol (2014) 0.84
Sequencing rare and common APOL1 coding variants to determine kidney disease risk. Kidney Int (2015) 0.82
Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis. Pediatr Nephrol (2012) 0.82
Discovery of new glomerular disease-relevant genes by translational profiling of podocytes in vivo. Kidney Int (2014) 0.82
The incidence of biopsy-proven glomerulonephritis in Cairo University, Egypt: a 5-year study. NDT Plus (2009) 0.81
Permeability factors in focal and segmental glomerulosclerosis. Adv Chronic Kidney Dis (2014) 0.81
Exome sequencing and in vitro studies identified podocalyxin as a candidate gene for focal and segmental glomerulosclerosis. Kidney Int (2013) 0.81
Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS. Clin J Am Soc Nephrol (2016) 0.81
Measures of kidney function by minimally invasive techniques correlate with histological glomerular damage in SCID mice with adriamycin-induced nephropathy. Sci Rep (2015) 0.80
Recurrent FSGS Postkidney Transplant: Moving the Needle Forward. Clin J Am Soc Nephrol (2016) 0.79
Multiple myeloma presenting with focal segmental glomerulosclerosis. South Asian J Cancer (2013) 0.78
Monozygotic transplantation: concerns and opportunities. Am J Transplant (2008) 0.78
FSGS Recurrence in Adults after Renal Transplantation. Biomed Res Int (2016) 0.76
Apolipoprotein L1 (APOL1) Variants (Vs) a possible link between Heroin-associated Nephropathy (HAN) and HIV-associated Nephropathy (HIVAN). Front Microbiol (2015) 0.76
Histological pattern of primary glomerular diseases among adult Sudanese patients: A single center experience. Indian J Nephrol (2013) 0.76
Unwinding focal segmental glomerulosclerosis. F1000Res (2017) 0.75
Refractory focal segmental glomerulosclerosis in the adult: complete and sustained remissions of two episodes of nephrotic syndrome after a single dose of rituximab. BMJ Case Rep (2014) 0.75
Treatment Strategies of Adult Primary Focal Segmental Glomerulosclerosis: A Systematic Review Focusing on the Last Two Decades. Biomed Res Int (2016) 0.75
The Impact of Histologic Variants on FSGS Outcomes. Int Sch Res Notices (2014) 0.75
Calcineurin Inhibitors in the Treatment of Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis of the Literature. Can J Kidney Health Dis (2017) 0.75
Plasma Exchange for the Recurrence of Primary Focal Segmental Glomerulosclerosis in Adult Renal Transplant Recipients: A Meta-Analysis. J Transplant (2015) 0.75
Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis. Sci Rep (2017) 0.75
FSGS: Diagnosis and Diagnostic Work-Up. Biomed Res Int (2016) 0.75
Treatment of Focal Segmental Glomerulosclerosis Recurrence in the Renal Allograft: A Report of Two Cases. Case Rep Nephrol Dial (2016) 0.75
Compound effects of aging and experimental FSGS on glomerular epithelial cells. Aging (Albany NY) (2017) 0.75
Insight to changing morphologic patterns of glomerulopathy in adult Pakistani patients: an institutional perspective. BMC Res Notes (2016) 0.75
Focal Segmental Glomerulosclerosis. Clin J Am Soc Nephrol (2017) 0.75
Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor. Biomed Res Int (2017) 0.75
Clinicopathological Analysis of Glomerular Disease of Adult Onset Nephrotic Syndrome in an Indian Cohort- A Retrospective Study. J Clin Diagn Res (2017) 0.75
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science (2010) 16.00
VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med (2008) 9.87
'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis (2012) 5.70
APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med (2013) 5.00
Early start of hemodialysis may be harmful. Arch Intern Med (2010) 3.83
The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med (2008) 3.76
CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science (2003) 3.61
Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int (2009) 3.58
Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Kidney Int (2012) 3.46
Initiation of dialysis at higher GFRs: is the apparent rising tide of early dialysis harmful or helpful? Kidney Int (2009) 3.36
A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol (2007) 3.23
The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol (2010) 3.15
US Renal Data System 2010 Annual Data Report. Am J Kidney Dis (2011) 2.90
Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol Dial Transplant (2009) 2.88
Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2005) 2.81
Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol (2011) 2.78
US Renal Data System 2013 Annual Data Report. Am J Kidney Dis (2014) 2.68
US Renal Data System 2012 Annual Data Report. Am J Kidney Dis (2013) 2.54
Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore) (2002) 2.51
Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15. Hum Mol Genet (2010) 2.51
Missed dialysis sessions and hospitalization in hemodialysis patients after Hurricane Katrina. Kidney Int (2009) 2.31
Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis (2007) 2.16
A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. Am J Kidney Dis (2010) 2.15
United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis (2009) 2.14
Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proc Natl Acad Sci U S A (2008) 2.12
African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans. Hum Mol Genet (2010) 2.11
Pirfenidone for diabetic nephropathy. J Am Soc Nephrol (2011) 2.04
Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis (2008) 2.01
Trends in the epidemiology of focal segmental glomerulosclerosis. Semin Nephrol (2003) 1.97
Risk of vascular access complications with frequent hemodialysis. J Am Soc Nephrol (2013) 1.93
Inducible podocyte-specific gene expression in transgenic mice. J Am Soc Nephrol (2003) 1.87
Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int (2008) 1.86
Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. J Clin Invest (2011) 1.81
Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study. Am J Nephrol (2009) 1.80
Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis. Clin J Am Soc Nephrol (2007) 1.80
HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics. Kidney Int (2012) 1.79
Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. Am J Physiol Renal Physiol (2007) 1.72
Epidemiology of acute kidney injury. Clin J Am Soc Nephrol (2008) 1.70
Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2003) 1.70
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int (2013) 1.69
Racial and ethnic disparities in end-stage kidney failure-survival paradoxes in African-Americans. Semin Dial (2007) 1.66
The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol (2010) 1.63
Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans. PLoS Genet (2011) 1.57
Human podocytes perform polarized, caveolae-dependent albumin endocytosis. Am J Physiol Renal Physiol (2014) 1.54
Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis. J Am Soc Nephrol (2004) 1.53
Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity (2002) 1.53
Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1. Kidney Int (2011) 1.52
Prevalence and trends of urinary incontinence in adults in the United States, 2001 to 2008. J Urol (2011) 1.50
Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy. Arch Pathol Lab Med (2009) 1.49
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol (2013) 1.49
A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis. J Clin Invest (2016) 1.48
Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. Nat Med (2011) 1.46
A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences. Am J Kidney Dis (2010) 1.46
De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease. Am J Physiol Renal Physiol (2009) 1.45
Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling. J Am Soc Nephrol (2009) 1.45
Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann Intern Med (2003) 1.44
Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A. Blood (2011) 1.41
Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease. Kidney Int (2010) 1.38
NPHS2 variation in sporadic focal segmental glomerulosclerosis. J Am Soc Nephrol (2007) 1.36
Renal pathology in Fabry disease. J Am Soc Nephrol (2002) 1.34
Lack of A1 adenosine receptors augments diabetic hyperfiltration and glomerular injury. J Am Soc Nephrol (2008) 1.32
Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model. Diabetes (2010) 1.29
Digital pathology evaluation in the multicenter Nephrotic Syndrome Study Network (NEPTUNE). Clin J Am Soc Nephrol (2013) 1.24
NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE review. Genet Med (2006) 1.23
Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population. Physiol Genomics (2005) 1.22
Patient preferences for in-center intense hemodialysis. Hemodial Int (2005) 1.20
In vitro models of TGF-beta-induced fibrosis suitable for high-throughput screening of antifibrotic agents. Am J Physiol Renal Physiol (2007) 1.17
Bioenergetic characterization of mouse podocytes. Am J Physiol Cell Physiol (2010) 1.16
Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney Int (2010) 1.16
Renal gene and protein expression signatures for prediction of kidney disease progression. Am J Pathol (2009) 1.15
Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J Am Soc Nephrol (2002) 1.14
Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa. PLoS One (2010) 1.14
Tenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infection. Pediatr Infect Dis J (2013) 1.14
Genetics of focal segmental glomerulosclerosis and human immunodeficiency virus-associated collapsing glomerulopathy: the role of MYH9 genetic variation. Semin Nephrol (2010) 1.13
PPARα and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders. Diabetes (2013) 1.12
Angiotensin II type 1 receptor blockade inhibits the development and progression of HIV-associated nephropathy in a mouse model. J Am Soc Nephrol (2007) 1.09
Natural history and treatment of renal involvement in Fabry disease. J Am Soc Nephrol (2002) 1.09
Conditionally immortalized human podocyte cell lines established from urine. Am J Physiol Renal Physiol (2009) 1.09
Sirolimus therapy of focal segmental glomerulosclerosis is associated with nephrotoxicity. Am J Kidney Dis (2007) 1.07
Parvovirus B19 and the kidney. Clin J Am Soc Nephrol (2007) 1.07
The NIDDK Central Repository at 8 years--ambition, revision, use and impact. Database (Oxford) (2011) 1.04
Focal glomerulosclerosis in proviral and c-fms transgenic mice links Vpr expression to HIV-associated nephropathy. Virology (2004) 1.04
Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group. Am J Kidney Dis (2009) 1.03
Dialysis initiation: what's the rush? Semin Dial (2013) 1.03
Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood. Metabolism (2010) 1.03
BK virus and SV40 co-infection in polyomavirus nephropathy. Transplantation (2002) 1.02
Tetracycline-inducible gene expression in conditionally immortalized mouse podocytes. Am J Nephrol (2008) 1.02
Cost-effectiveness of screening for microalbuminuria among African Americans. J Am Soc Nephrol (2012) 1.02
Modulation of podocyte phenotype in collapsing glomerulopathies. Microsc Res Tech (2002) 1.00
Live and deceased donor kidney transplantation in patients aged 75 years and older in the United States. Int Urol Nephrol (2005) 1.00
Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study. Eur J Clin Invest (2015) 1.00
Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group. Clin J Am Soc Nephrol (2008) 0.97
The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans. Am J Nephrol (2010) 0.97
Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor {gamma} and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy. Mol Endocrinol (2007) 0.97
Renal fibrosis. Front Biosci (2003) 0.95
Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy. Am J Physiol Renal Physiol (2007) 0.95